• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Aptar Pharma banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

People

Nocion Therapeutics appoints Matthew Frankel as Chief Medical Officer

Nocion Therapeutics, which is developing inhaled dry powder taplucainium (NOC-110, formerly NTX-1175) for the treatment of chronic cough, has announced the appointment of Matthew Frankel as Chief Medical Officer. Frankel was most recently Chief Medical Officer at Chemomab Therapeutics and previously served as VP, Clinical Development and Medical Affairs, Specialty … [Read more...] about Nocion Therapeutics appoints Matthew Frankel as Chief Medical Officer

Kindeva names Melanie Cerullo as Chief Quality Officer

CDMO Kindeva has announced the appointment of Melanie Cerullo as Chief Quality Officer. Cerullo was most recently Chief Quality and Regulatory Officer at Recipharm's ReciBioPharm business unit and previously served in quality roles at Wave Life Sciences, Ameridose, and Amgen. Since the beginning of 2024, Kindeva has expanded its facilities with the acquisition of … [Read more...] about Kindeva names Melanie Cerullo as Chief Quality Officer

HCmed names Chris Vernall as Executive VP of Business Development

Nebulizer maker HCmed has announced the appointment of Chris Vernall as its new Executive VP of Business Development. Vernall started his career as an inhalation scientist at Nanopharm and later returned to Nanopharm as Director of Business Development after a stint at Intertek. He then served in a similar role at Vectura before returning to Intertek in 2022 as … [Read more...] about HCmed names Chris Vernall as Executive VP of Business Development

Orbia announces appointments in its MDI propellants business

Orbia Fluor & Energy Materials (formerly Koura) has announced the appointments of a new General Manager, Global Commercial Director, UK Operations Director, and Technical Manager for its Pharma Business Unit, which includes Zephex brand MDI propellants, including its HFA 152a LGWP propellant. All of the newly announced appointments took place in the second … [Read more...] about Orbia announces appointments in its MDI propellants business

Joshua Ziel joins Bryn Pharma as CEO

Intranasal epinephrine developer Bryn Pharma announced that former Aerami Therapeutics Chief Operating Officer Joshua Ziel has joined the company as CEO, succeeding Sandy Loreaux. Prior to joining Aerami in 2022, Ziel held management positions at Syneos Health and at advertising agency WPP. According to the company, Loreaux has resigned as CEO due to family matters … [Read more...] about Joshua Ziel joins Bryn Pharma as CEO

Transpire Bio names new VP of Manufacturing & Operations, Chief Commercial Officer, and Head of Quality Assurance

Inhaled drug developer Transpire Bio has announced the hires of Timothy Lutz as VP of Manufacturing and Operations; Stuart Loesch as Chief Commercial Officer; and Todd Sunstrom as Head of Quality Assurance. The company recently announced the initiation of a Phase 1 trial for a generic inhaler for asthma and COPD. Last October, Transpire officially opened its new … [Read more...] about Transpire Bio names new VP of Manufacturing & Operations, Chief Commercial Officer, and Head of Quality Assurance

Synairgen names Mark Parry-Billings as new Chairman of the Board

UK-based Synairgen, which is developing SNG001 inhaled interferon-beta-1a, announced that former Chiesi Global Head of Drug Development Mark Parry-Billings will succeed Simon Shaw as Chairman of the Board. Shaw will retire in October 2024. Prior to joining Chiesi in 2011, Parry-Billings was CEO of Topigen Pharmaceuticals, which was sold to Pharmaxis in 2010. His … [Read more...] about Synairgen names Mark Parry-Billings as new Chairman of the Board

Leyden Labs names Jintanat Ananworanich as new Chief Medical Officer

Nasal drug developer Leyden Laboratories announced that former Moderna vaccine development executive Jintanat Ananworanich has joined the company as Chief Medical Officer. Ananworanich was most recently Executive Director of clinical development at Moderna, and her previous experience includes roles as Clinical Development Leader at the Bill and Melinda Gates Medical … [Read more...] about Leyden Labs names Jintanat Ananworanich as new Chief Medical Officer

MVIC names Mats Håkansson as new CEO

The Medicon Valley Inhalation Consortium (MVIC) announced that marketing specialist Mats Håkansson will take over the CEO role from Lars Asking. According to the announcement, Asking, who had served as the CEO of MVIC since 2017, will continue to lead projects for the consortium, which acts as a contract research organization. According to Håkansson's LinkedIn … [Read more...] about MVIC names Mats Håkansson as new CEO

Nocion announces appointments of Catherine Bonuccelli and Joan Shaw

Nocion Therapeutics, whose taplucainium (NTX-1175) DPI is in Phase 2 development for the treatment of chronic cough, has announced the appointments of two former Bellus Health executives, naming Catherine Bonuccelli to the scientific advisory board and Joan Shaw as Senior VP, Clinical Operations. Both were involved in the clinical development of Bellus' camlipixant … [Read more...] about Nocion announces appointments of Catherine Bonuccelli and Joan Shaw

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 39
  • Next Page »

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Merxin We Make Inhalers banner
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews